Cargando…

Progress in the Development of a Cervical Cancer Vaccine

Persistent infection by ‘high risk’ genotypes of human papilloma virus (HPV) is necessary but not sufficient for the development of over 98% of cervical cancers. Thus the development of vaccines that prevent HPV transmission represent an important opportunity to prevent cervical cancer. There are se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winters, Ursula, Roden, Richard, Kitchener, Henry, Stern, Peter
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2006
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936262/ https://www.ncbi.nlm.nih.gov/pubmed/18360601

Ejemplares similares

Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
por: Daayana, S, et al.
Publicado: (2010)

Cervarix(™): a vaccine for the prevention of HPV 16, 18-associated cervical cancer
por: Monie, Archana, et al.
Publicado: (2008)

Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases
por: Olczak, Pola, et al.
Publicado: (2020)

Optimising future cervical screening strategies
por: Kitchener, Henry
Publicado: (2019)

Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions
por: Wang, Joshua W., et al.
Publicado: (2014)

Opportunities to improve immune-based prevention of HPV-associated cancers
por: Stern, Peter L., et al.
Publicado: (2019)

The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2022)

Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
por: Tsiachristas, Apostolos, et al.
Publicado: (2017)

Current status and progress of the development of prostate cancer vaccines
por: Wang, Jie, et al.
Publicado: (2023)

Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening
por: Sargent, Alex, et al.
Publicado: (2019)

Progress in immunocytochemical staining for cervical cancer screening
por: Sun, Hengzi, et al.
Publicado: (2019)

Progress and challenges in TB vaccine development
por: Voss, Gerald, et al.
Publicado: (2018)

Progress in the Development of Universal Influenza Vaccines
por: Sun, Wenqiang, et al.
Publicado: (2020)

Cervical cancer in India and HPV vaccination
por: Kaarthigeyan, K.
Publicado: (2012)

A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent
por: Brabin, Loretta, et al.
Publicado: (2007)

The Role of Galectins in Cervical Cancer Biology and Progression
por: Wang, Lufang, et al.
Publicado: (2018)

SMAGP a novel biomarker of cervical cancer development and progression
por: Jia, Yongqin, et al.
Publicado: (2018)

Progress in the Development of Subunit Vaccines against Malaria
por: Skwarczynski, Mariusz, et al.
Publicado: (2020)

Current Progress in the Development of Zika Virus Vaccines
por: Zhou, Kehui, et al.
Publicado: (2021)

Current progress in the development of prophylactic and therapeutic vaccines
por: Li, Tingting, et al.
Publicado: (2022)

Progress towards the Development of a Universal Influenza Vaccine
por: Wang, Wen-Chien, et al.
Publicado: (2022)

Immunizing against Anogenital Cancer: HPV Vaccines
por: Pogoda, Cloe S., et al.
Publicado: (2016)

Research Progress of Immuno-Inhibitory Receptors in Gynecological Cervical Cancer
por: Li, Yang, et al.
Publicado: (2023)

Progress and controversies in developing cancer vaccines
por: Slingluff, Craig L, et al.
Publicado: (2005)

Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries
por: Natunen, Kari, et al.
Publicado: (2011)

The Progress of Methylation Regulation in Gene Expression of Cervical Cancer
por: Feng, Chunyang, et al.
Publicado: (2018)

Cervical cancer stem cells and other leading factors associated with cervical cancer development
por: Mendoza-Almanza, Gretel, et al.
Publicado: (2019)

A review of the research progress in T-lymphocyte immunity and cervical cancer
por: Zhang, Lina, et al.
Publicado: (2020)

SMAGP a Novel Biomarker of Cervical Cancer Development and Progression [Erratum]
Publicado: (2020)

Increasing rates of cervical cancer in young women in England: an analysis of national data 1982–2006
por: Foley, G, et al.
Publicado: (2011)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

Zika Vaccine Development—Current Progress and Challenges for the Future
por: Maslow, Joel N.
Publicado: (2019)

Current progress in the development of a prophylactic vaccine for HIV-1
por: Gamble, Lena J, et al.
Publicado: (2010)

Matrix metalloproteinase-induced cervical extracellular matrix remodelling in pregnancy and cervical cancer
por: Amabebe, Emmanuel, et al.
Publicado: (2022)

Progress of vaccine and drug development for Ebola preparedness
por: Choi, Woo Young, et al.
Publicado: (2015)

RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates
por: Huber, Bettina, et al.
Publicado: (2021)

Heavy menstrual bleeding management during the Covid pandemic
por: Winters, Ursula, et al.
Publicado: (2021)

Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
por: Chin’ombe, Nyasha, et al.
Publicado: (2014)

Proposal for cervical cancer screening in the era of HPV vaccination
por: Ouh, Yung-Taek, et al.
Publicado: (2018)

Key Molecular Events in Cervical Cancer Development
por: Balasubramaniam, Shandra Devi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o65m5ot6c5qnqe80j1ipgegca9